» Articles » PMID: 38797240

Single Cell RNA Sequencing of Human Eosinophils from Nasal Polyps Reveals Eosinophil Heterogeneity in Chronic Rhinosinusitis Tissue

Abstract

Background: Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by type 2 inflammation in the United States, but the actual roles that eosinophils play in CRSwNP remain largely unclear.

Objective: To reveal the roles and heterogeneity of eosinophils in nasal polyp (NP) tissue, we performed single cell RNA sequencing (scRNA-Seq) analysis of NP tissue.

Methods: Sinonasal tissues (NP and control sinus tissue) and patient matched peripheral blood (PB) samples were obtained from 5 control patients and 5 patients with CRSwNP. Eosinophils were enriched before processing for scRNA-Seq. The gene expression profiles in eosinophils were determined by microwell-based scRNA-Seq technology (BD Rhapsody platform). We predicted the overall function of NP eosinophils by Gene Ontology (geneontology.org) enrichment and pathway analyses and confirmed expression of selected genes by flow cytometry.

Results: After filtering out contaminating cells, we detected 5,542 eosinophils from control PB, 3,883 eosinophils from CRSwNP PB, 101 eosinophils from control sinus tissues (not included in further analyses), and 9,727 eosinophils from NPs by scRNA-Seq. We found that 204 genes were downregulated and 354 genes upregulated in NP eosinophils compared to all PB eosinophils (>1.5-fold, P < .05). Upregulated genes in NP eosinophils were associated with activation, cytokine-mediated signaling, growth factor activity, NF-κB signaling, and antiapoptotic molecules. NP eosinophils displayed 4 clusters revealing potential heterogeneity of eosinophils in NP tissue.

Conclusions: Elevated eosinophils in NP tissue appear to exist in several subtypes that may play important pathogenic roles in CRSwNP, in part by controlling inflammation and hyperproliferation of other cells.

Citing Articles

Single-Cell Analysis: A Method for In-Depth Phenotyping of Cells Involved in Asthma.

Rodriguez-Gonzalez D, Guillen-Sanchez G, Del Pozo V, Canas J Int J Mol Sci. 2024; 25(23).

PMID: 39684345 PMC: 11641648. DOI: 10.3390/ijms252312633.


Endotyping in Chronic Rhinosinusitis-An EAACI Task Force Report.

Toppila-Salmi S, Reitsma S, Hox V, Gane S, Eguiluz-Gracia I, Shamji M Allergy. 2024; 80(1):132-147.

PMID: 39641584 PMC: 11724251. DOI: 10.1111/all.16418.


Analysis of human neutrophils from nasal polyps by single-cell RNA sequencing reveals roles of neutrophils in chronic rhinosinusitis.

Iwasaki N, Poposki J, Kidoguchi M, Oka A, Klingler A, Stevens W J Allergy Clin Immunol. 2024; 155(3):843-855.

PMID: 39522652 PMC: 11875937. DOI: 10.1016/j.jaci.2024.10.032.

References
1.
Liu L, Sedgwick J, Bates M, Vrtis R, Gern J, Kita H . Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge. J Immunol. 2002; 169(11):6452-8. DOI: 10.4049/jimmunol.169.11.6452. View

2.
Kanno Y . The uPA/uPAR System Orchestrates the Inflammatory Response, Vascular Homeostasis, and Immune System in Fibrosis Progression. Int J Mol Sci. 2023; 24(2). PMC: 9866279. DOI: 10.3390/ijms24021796. View

3.
Laidlaw T, Prussin C, Panettieri R, Lee S, Ferguson B, Adappa N . Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size. Laryngoscope. 2018; 129(2):E61-E66. DOI: 10.1002/lary.27564. View

4.
Han J, Bachert C, Fokkens W, Desrosiers M, Wagenmann M, Lee S . Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021; 9(10):1141-1153. DOI: 10.1016/S2213-2600(21)00097-7. View

5.
Stevens W, Peters A, Tan B, Klingler A, Poposki J, Hulse K . Associations Between Inflammatory Endotypes and Clinical Presentations in Chronic Rhinosinusitis. J Allergy Clin Immunol Pract. 2019; 7(8):2812-2820.e3. PMC: 6842686. DOI: 10.1016/j.jaip.2019.05.009. View